Stay updated on VX15/Avelumab Combo in NSCLC Clinical Trial
Sign up to get notified when there's something new on the VX15/Avelumab Combo in NSCLC Clinical Trial page.

Latest updates to the VX15/Avelumab Combo in NSCLC Clinical Trial page
- Check2 days agoChange DetectedThe government funding/status notice was removed from the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedThe two screenshots depict the same study details page with no changes to the core information (title, conditions, interventions, inclusion/exclusion criteria, enrollment, or locations).SummaryDifference0.4%

- Check46 days agoChange DetectedUpdate: the page version is updated from v3.0.2 to v3.2.0. No other content changes detected.SummaryDifference0.1%

- Check47 days agoChange DetectedVersion updated from v3.0.2 to v3.1.0; no substantive content changes detected.SummaryDifference0.1%

- Check61 days agoChange DetectedThe page now shows Revision: v3.0.2, replacing v3.0.1. The Back to Top element was removed, a minor UI change with no substantive content impact.SummaryDifference0.1%

- Check68 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content or important information.SummaryDifference0.1%

Stay in the know with updates to VX15/Avelumab Combo in NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the VX15/Avelumab Combo in NSCLC Clinical Trial page.